Saxagliptin intervention alleviated diabetic nephropathy by targeting NLRP3 in the rodent model (Birnbaum et al., 2016), and notably, gardenoside suppressed NLRP3 through autophagy in the microglial model (Fu et al., 2020). This evidence concerns the gene NLRP3 and diabetic kidney disease.